Universal Biosensors, Inc. (UBI.AX)
AUD 0.06
(-1.61%)
AUD 0.06
(-1.61%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 4.28 Million AUD | 55.21% |
| 2022 | 2.13 Million AUD | 1.58% |
| 2021 | 2.1 Million AUD | 237.95% |
| 2020 | 623.08 Thousand AUD | -81.26% |
| 2019 | 3.32 Million AUD | -95.03% |
| 2018 | 66.94 Million AUD | 215.18% |
| 2017 | 21.24 Million AUD | 20.14% |
| 2016 | 17.67 Million AUD | 14.84% |
| 2015 | 15.39 Million AUD | 71.55% |
| 2014 | 8.97 Million AUD | 160.35% |
| 2013 | 3.44 Million AUD | -68.64% |
| 2012 | 10.99 Million AUD | 543.3% |
| 2011 | 1.7 Million AUD | -82.04% |
| 2010 | 9.51 Million AUD | -55.58% |
| 2009 | 21.41 Million AUD | 1391.83% |
| 2008 | 1.43 Million AUD | 238.33% |
| 2007 | -1.03 Million AUD | -139.1% |
| 2006 | 2.65 Million AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 624.76 Thousand AUD | -34.67% |
| 2024 Q2 | 925.2 Thousand AUD | 48.09% |
| 2024 Q3 | 592.28 Thousand AUD | -35.98% |
| 2023 FY | 3.31 Million AUD | 55.21% |
| 2023 Q2 | 812.95 Thousand AUD | -7.28% |
| 2023 Q1 | 876.77 Thousand AUD | 80.77% |
| 2023 Q3 | 1.38 Million AUD | 70.96% |
| 2023 Q4 | 956.39 Thousand AUD | -31.19% |
| 2022 Q3 | 409.58 Thousand AUD | -50.39% |
| 2022 Q4 | 485.01 Thousand AUD | 18.42% |
| 2022 FY | 2.13 Million AUD | 1.58% |
| 2022 Q1 | 418.84 Thousand AUD | 56.38% |
| 2022 Q2 | 825.58 Thousand AUD | 97.11% |
| 2021 Q1 | 710.5 Thousand AUD | 1.82% |
| 2021 Q3 | 472.46 Thousand AUD | -27.86% |
| 2021 Q4 | 267.83 Thousand AUD | -43.31% |
| 2021 Q2 | 654.89 Thousand AUD | -7.83% |
| 2021 FY | 2.1 Million AUD | 237.95% |
| 2020 Q2 | -12.42 Thousand AUD | 89.46% |
| 2020 Q3 | 55.63 Thousand AUD | 547.64% |
| 2020 FY | 623.08 Thousand AUD | -81.26% |
| 2020 Q1 | -117.9 Thousand AUD | -124.71% |
| 2020 Q4 | 697.78 Thousand AUD | 1154.26% |
| 2019 Q3 | 590.47 Thousand AUD | -46.68% |
| 2019 FY | 3.32 Million AUD | -95.03% |
| 2019 Q4 | 477.11 Thousand AUD | -19.2% |
| 2019 Q2 | 1.1 Million AUD | -3.76% |
| 2019 Q1 | 1.15 Million AUD | -85.47% |
| 2018 FY | 66.94 Million AUD | 215.18% |
| 2018 Q4 | 7.92 Million AUD | -83.09% |
| 2018 Q3 | 46.83 Million AUD | 796.79% |
| 2018 Q2 | 5.22 Million AUD | -25.1% |
| 2018 Q1 | 6.97 Million AUD | 65.29% |
| 2017 Q4 | 4.21 Million AUD | -17.17% |
| 2017 FY | 21.24 Million AUD | 20.14% |
| 2017 Q1 | 6.76 Million AUD | 62.47% |
| 2017 Q2 | 5.16 Million AUD | -23.73% |
| 2017 Q3 | 5.09 Million AUD | -1.34% |
| 2016 Q1 | 4.91 Million AUD | 117.84% |
| 2016 FY | 17.67 Million AUD | 14.84% |
| 2016 Q3 | 3.25 Million AUD | -39.13% |
| 2016 Q2 | 5.34 Million AUD | 8.92% |
| 2016 Q4 | 4.16 Million AUD | 27.96% |
| 2015 Q2 | 3.89 Million AUD | 28.56% |
| 2015 Q4 | 2.25 Million AUD | -58.95% |
| 2015 Q3 | 5.49 Million AUD | 40.85% |
| 2015 Q1 | 3.03 Million AUD | 34.39% |
| 2015 FY | 15.39 Million AUD | 71.55% |
| 2014 Q1 | 1.33 Million AUD | 48.49% |
| 2014 FY | 8.97 Million AUD | 160.35% |
| 2014 Q4 | 2.25 Million AUD | 29.57% |
| 2014 Q3 | 1.74 Million AUD | 15.53% |
| 2014 Q2 | 1.5 Million AUD | 12.83% |
| 2013 Q2 | 1 Million AUD | -0.81% |
| 2013 Q1 | 1.01 Million AUD | -45.79% |
| 2013 FY | 3.44 Million AUD | -68.64% |
| 2013 Q4 | 899.58 Thousand AUD | 72.9% |
| 2013 Q3 | 520.29 Thousand AUD | -48.45% |
| 2012 Q3 | 4.13 Million AUD | 12.93% |
| 2012 FY | 10.99 Million AUD | 543.3% |
| 2012 Q2 | 3.66 Million AUD | 180.4% |
| 2012 Q1 | 1.3 Million AUD | 0.0% |
| 2012 Q4 | 1.87 Million AUD | -54.65% |
| 2011 Q1 | 9750.00 AUD | 0.0% |
| 2011 FY | 1.7 Million AUD | -82.04% |
| 2011 Q3 | 97.04 Thousand AUD | 205.62% |
| 2011 Q2 | -91.88 Thousand AUD | -1042.4% |
| 2010 Q1 | 1.63 Million AUD | 0.0% |
| 2010 Q3 | 1.47 Million AUD | 154.62% |
| 2010 Q2 | 579.45 Thousand AUD | -64.53% |
| 2010 FY | 9.51 Million AUD | -55.58% |
| 2009 Q3 | 1.04 Million AUD | 70.69% |
| 2009 FY | 21.41 Million AUD | 1391.83% |
| 2009 Q2 | 615.15 Thousand AUD | -66.58% |
| 2009 Q1 | 1.84 Million AUD | 0.0% |
| 2008 FY | 1.43 Million AUD | 238.33% |
| 2007 FY | -1.03 Million AUD | -139.1% |
| 2006 FY | 2.65 Million AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| 4DMedical Limited | 3.51 Million AUD | -21.816% |
| Adherium Limited | -640.83 Thousand AUD | 768.649% |
| Aroa Biosurgery Limited | 53.98 Million AUD | 92.063% |
| Atomo Diagnostics Limited | 1.43 Million AUD | -198.248% |
| Anteris Technologies Ltd | 2.51 Million AUD | -70.228% |
| Control Bionics Limited | 3.67 Million AUD | -16.668% |
| CardieX Limited | 10.1 Million AUD | 57.607% |
| Compumedics Limited | 26.06 Million AUD | 83.562% |
| Cochlear Limited | 1.69 Billion AUD | 99.747% |
| CleanSpace Holdings Limited | 11.35 Million AUD | 62.278% |
| Cyclopharm Limited | 4.49 Million AUD | 4.723% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 61.807% |
| Nova Eye Medical Limited | 20.19 Million AUD | 78.78% |
| HeraMED Limited | -504.09 Thousand AUD | 950.026% |
| Imricor Medical Systems, Inc. | -1.99 Million AUD | 315.011% |
| ImpediMed Limited | 9 Million AUD | 52.416% |
| InhaleRx Limited | 1.2 Million AUD | -255.878% |
| LBT Innovations Limited | -2.91 Million AUD | 246.895% |
| Micro-X Limited | 5.73 Million AUD | 25.31% |
| Neurotech International Limited | -5867.00 AUD | 73134.549% |
| OncoSil Medical Limited | 55.63 Thousand AUD | -7602.288% |
| PolyNovo Limited | 36.08 Million AUD | 88.125% |
| Respiri Limited | 456.91 Thousand AUD | -837.799% |
| SomnoMed Limited | 55.13 Million AUD | 92.228% |
| Uscom Limited | 3.11 Million AUD | -37.527% |
| Visioneering Technologies, Inc. | -271.11 Thousand AUD | 1680.481% |